Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Accumulated Expenses: 2012-2024

Historic Other Accumulated Expenses for Veracyte (VCYT) over the last 9 years, with Dec 2024 value amounting to $19,000.

  • Veracyte's Other Accumulated Expenses fell 92.13% to $7,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $7,000, marking a year-over-year decrease of 92.13%. This contributed to the annual value of $19,000 for FY2024, which is 81.19% down from last year.
  • Veracyte's Other Accumulated Expenses amounted to $19,000 in FY2024, which was down 81.19% from $101,000 recorded in FY2023.
  • Veracyte's Other Accumulated Expenses' 5-year high stood at $231,000 during FY2021, with a 5-year trough of $19,000 in FY2024.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $101,000 (2023), whereas its average is $102,000.
  • Data for Veracyte's Other Accumulated Expenses shows a maximum YoY plummeted of 81.19% (in 2024) over the last 5 years.
  • Yearly analysis of 4 years shows Veracyte's Other Accumulated Expenses stood at $231,000 in 2021, then fell by 19.48% to $186,000 in 2022, then tumbled by 45.70% to $101,000 in 2023, then slumped by 81.19% to $19,000 in 2024.